ABSTRACT. Using an in situ isolated salt-perfused rabbit lung preparation, we investigated the functional ontogeny of pulmonary vascular dopamine receptors. In rabbits from 1 to 23 d of age, we measured pulmonary vascular vasodilatory responses to the peripheral vascular dopamine receptor (DAI) agonist, fenoldopam, and sodium nitroprusside during prostaglandin F2,-induced pulmonary vasoconstriction. In separate experiments, the lungs were pretreated with the DAI receptor blocker, S C H 23390, before prostaglandin F20, fenoldopam, and sodium nitroprusside.
group) were ventilated and perfused. After a stabilization period, prostaglandin Flu was infused into the pulmonary inflow catheter in a concentration range to yield a sustained rise in mean pulmonary artery pressure (4.9 f 0.2 mm Hg). Fenoldopam was injected into the pulmonary artery a t doses of 0.01, 0.1, 1.0, and 10 pg/g after a recovery period, sodium nitroprusside (0.2 pg/g) was injected into the pulmonary artery, and the resultant changes in vascular pressure were recorded. Across all age groups, with and without DAI receptor blockade, sodium nitroprusside-induced vasodilation was similar (-2.7 + 0.2 mm Hg) and was considered reference vasodilation. The fenoldopam vasodilation response was considered a percentage of the sodium nitroprusside reference. Response to fenoldopam varied significantly ( p < 0.05 by analysis of variance) across the six age groups, with a maximum at 3-5 d of age. Pretreatment with S C H 23390, a selective DAl-blocking agent, significantly attenuated fenoldopam vasodilation in all but the youngest animals (age 0-2 d), in which no blockade effect was noted. We conclude that there are ~ -significant age-related changes in the vascular responses to fenoldopam. We speculate that endogenous dopamine and vascular dopamine receptors may play a role in mediating changes in the transitional, pulmonary circulation. Supported by a grant from the American Heart Association (West Virginia Chapter).
Endogenous dopamine interacts with a family of receptors within the CNS and peripherally within various organs and vascular beds. Dopamine-dopamine receptor interactions have a role in endocrine integrity. movement. behavior, renal function, and hemodynamics (1. 2). Recent studies have suggested that dopamine and peripheral, postsynaptic vascular. and renal tubule dopamine receptors ( D A I ) are important in the modulation of systemic blood pressure and renal function in the fetus and newborn (2-6). We wondered whether dopamine receptor activity plays a role in neonatal pulmonary vascular reactivity.
In these studies. we have investigated the functional maturation of DAl-type receptors in the pulmonary vasculature of rabbits. We approached the evaluation of DAI receptor function in newborns by using the DAI receptor agonist-antagonist pair of fenoldopam and SCH 23390 in a preconstricted, isolated perfused rabbit lung model. This agonist-antagonist pair provides a powerful tool for delineating functional activity of dopamine receptors (6-8). Our data show changes in vascular dopamine receptor responsiveness in neonatal rabbits occurring during the first 3 wk of life. These changes may play a role in modulation of pulmonary hemodynamics in the newborn.
MATERIALS A N D M E T H O D S
These experiments were approved by the Animal Care and Use Committee at West Virginia University. Pregnant. New Zealand White rabbit does delivered spontaneously at term ( 3 1 d gestation). The pups were nested with the mother and randomly assigned to a perfusion group. Rabbits were divided on the basis of age into six perfusion groups. which are detailed in Table I .
On the day of perfusion, the rabbit pup was removed from the nest. taken to the laboratory. and weighed. The animal was instrumented for perfusion as follows. The rabbit pup was anesthetized with pentobarbitol(50 pg/g body weight) injected intraperitoneally. A tracheostomy was performed and mechanical ventilation begun (0: = 0.21. CO: = 0.05. N2 = 0.74, tidal volume = 1.2 mL/100 g. rate = 30 breathslmin). The heart and lungs were exposed via a median sternotomy. heparin ( I U/g body weight) was injected into the right ventricle. and a ligature was placed loosely around the pulmonic and aortic trunks. A perfusion cannula was inserted into the main pulmonary artery through a small incision in the right ventricular outflow tract. The ligature was tightened around both the pulmonary artery and aorta and an infusion begun with Earl's Balanced Salt Solution with 21 mM sodium bicarbonate and 3% bovine albumin added. The pH was adjusted to 7.40. The tip of the left ventricle was excised and a second cannula introduced into the left atrium and fixed into position with a ligature around both ventricles. The ductus arteriosus was identified and, if present. ligated with a fine suture ligature (between 3 and 5 d of age, the ductus arteriosus was noted to constrict).
The perfusate was pumped from a syringe reservoir. at constant ONTOGENY OF PULMONARY DAI RECEPTORS 229 flow rate, through a heat exchanger (temperature = 37°C) and into the pulmonary artery, where it is circulated through the lungs and returned to the reservoir via the left atrial catheter. Mean pulmonary artery pressure and mean left atrial pressure (mm Hg) were continuously measured by pressure transducers and monitored on a physiologic recorder. The experimental protocols were designed to investigate the dose-response characteristics of selective DAI receptor stimulation with fenoldopam on the pulmonary vascular bed during elevated pulmonary artery pressure as a function of age (Fig. I) . Fenoldopam mesylate is a benzapine compound developed as an antihypertensive agent. It is a highly selective DAI receptor agonist (9, 10). Because tachyphylaxis is generally not noted with fenoldopam ( 1 1 ), a sequential dose-response protocol was developed. The fenoldopam doses were chosen on the basis of previous work from our laboratory (6-8) and pilot studies in rabbits.
As a test for DAI receptor selectivity, the fenoldopam doseresponse experiments were repeated in the presence of the highly selective DAI receptor blocker, SCH 23390 ( 12-14). This drug has no known cross-reactivity to DA2-, a-. or 8-adrenergic. histaminergic, serotonergic, or cholinergic receptors. From our previous experience, SCH 23390 infused at 0.01 ~g/g.min-' does not alter baseline pressure or other lung perfusion characteristics, yet significantly blocks the fenoldopam effect (6-8).
Finally, as a measure of age-independent vasodilation, with and without DA, blockade, sodium nitroprusside (0.2 ~g / g body weight) was used. Sodium nitroprusside causes endotheliumindependent vasodilation via stimulation of soluble guanylate cyclase within the vascular smooth muscle. As a result, the vasodilator response to sodium nitroprusside does not vary with age (15, 16). A 10-to 15-min stabilization period began each experiment. Flow was set to greater than 0.050 mL/gmin-I. and left atrial pressure was adjusted to 1-2 mm Hg. A solution of PGF?,, (0.25 pg/g.min-I) was infused into the pulmonary artery to elevate the mean pulmonary artery pressure with no alteration in mean left atrial pressure. Fenoldopam. in doses of 0.0 I . 0.1. 1 .O. and 10.0 ~g / g of rabbit body weight, was serially injected into the pulmonary artery. and the maximum changes in pulmonary vascular pressure (mm Hg) were recorded. After an additional 10 min, sodium nitroprusside (0.2 pg/g) was injected into the pulmonary artery, and the resultant change in pulmonary artery pressure (mm Hg) recorded. In 2 1 separate experiments. a solution of the selective DAI blocker SCH 23390 was infused at 0.01 ccg/g.min-l into the pulmonary artery before the PGF:,, was infused. Fenoldopam at doses of 0. I and I . O ~g / g was used in these experiments. At the end of all experiments. the lungs were removed, weighed, dried in a drying oven, and reweighed. Wetto-dry lung weight ratios were calculated as a determination of lung edema. From our previous experience. a wet/dry ratio of 6.0 or less is indicative of little or no edema formation (6-8) and. in general. a good perfusion.
For all experiments, the sodium nitroprusside-induced vasodilation was considered the reference vasodilation. This response was given an arbitrary value of 100% vasodilation. The degree of vasodilation attained by fenoldopam was subsequently represented as a percentage of the nitroprusside reference. The overall data were analyzed by single-factor ANOVA with age group as the independent variable and percent change in pulmonary pressure as the dependent variable. Significant differences among different age groups at each dose of fenoldopam were determined by the Fisher's protected least squares difference test and the Scheffe I: test. Comparisons of fenoldopam vasodilation with and without DAI blockade within each age group were made by single-factor ANOVA. All data are presented as mean + SEM. Figure 2 . A vasodilatory response to fenoldopam is noted even in the youngest age group (group 1). The dose-response curve then shifts to the left, with the maximum vasodilatory responses to fenoldopam noted in age group 2. Fenoldopam vasodilation at doses of 0.1 and 1.0 pg/g in age group 2 was significantly higher than in all other age groups. The dose-response curve then shifts rightward over the following 2 wk and remains at these levels to the weanling age.
Fenoldopam vasodilation uftc.r 0.4 bloc-kadt~ rr,itli SCII 23390. To investigate the degree of DA, receptor specificity with the fenoldopam-induced vasodilation, the experiments were repeated in the presence of the selective DAl-blocking agent SCH 23390. As can be noted in Figure 3 . treatment with this dopamine receptor antagonist significantly attenuates the vasodilatory responses to fenoldopam in all age groups except group 1. in which no effect of DA, blockade was noted.
DISCUSSION
The isolated perfused lung has proven to be a useful model for detailing the effects of dopamine receptor manipulation on the pulmonary vasculature (7, 8) . In these present experiments, we have reexamined the effects of DAI stimulation on the preconstricted pulmonary vascular bed of rabbits as a function of age. newborn to weanling. We have shown that there are distinct differences in DAI receptor responsiveness and receptor selectivity that change with the age of the animals.
Pulmonary vascular dynamics are complex in the newborn mammal, because there are major transitions from fetal to newborn circulations and ultimately to the development of adult blood flow patterns. Control of pulmonary vascular tone in the fetus and the transition to the newborn are dictated by many interacting mechanisms, including environmental factors (pH, hypoxia, etc), as well as the production and metabolism of a variety of vasoactive compounds within the pulmonary vessels including bradykinin and other vasoactive peptides. products of arachidonic acid metabolism. and endothelium-derived factors (endothelium-derived relaxing factor. endothelin) ( 17. 18). Autonomic control of vascular tone in terms of sympathetic input seems to have a limited role in the fetal and transitional circulation because innervation has been classically thought to be incomplete at birth ( 19. 20) .
Recent data suggest that peripheral dopaminergic activity may also be important in modulating the hemodynamics of the fetus and newborn. In the fetal lamb. endogenous dopamine plays an important role in control of renal function. primarily by affecting sodium excretion. These dopamine-DAl receptor interactions occur at the tubular level, in response to dopamine produced locally (2-5). In the fetal and neonatal lamb. blockade of peripheral DAI receptors with SCH 23390 causes significant alterations in heart rate. cardiac output. systemic and pulmonary artery pressure. and systemic and pulmonary vascular resistance (5. 6). These data suggest that endogenous dopamine has numerous physiologic actions in the fetus and newborn. The renal tubule DAI receptor activation is involved in control of vascular volume status. whereas vascular DAI receptor occupation affects multiple vascular systems of these animals. These vascular dopamine receptors not only have an affinity for dopamine receptor agonists such as fenoldopam. but also can effect vascular hemodynamics and seem to be maintained in a chronically active state. presumably by endogenous dopamine (5. 6, 1 1. 2 1 ).
At birth and for the first 2 d of life. there is a dose-dependent vasodilatory response to fenoldopam. This vasodilatory response. however. is not necessarily the result of DAI receptor activation. as demonstrated by the failure to reach a dose-response saturation point typical of a drug-receptor interaction (Fig. 2) (22) . Furthermore. SCH 23390 failed to block the fenoldopam-induced vasodilation. supporting the idea of a vasodilating effect mediated by an atypical DAI receptor at best (Fig. 3) . Postnatal maturation of dopamine receptor responsiveness occurs at different time courses for different circulations (73. 24): therefore. the functional ontogeny of pulmonary vascular dopamine receptors may not necessarily parallel the patterns noted in the renal tubules and vascular beds of other organ systems. From our data. it appears that maturation of pulmonary dopamine (DAI) receptors does differ from that previously noted in the fetal and newborn kidney. The observations of highly uncharacteristic effects of fenoldopam and SCH 23390 in age group 1 may be the result of multiple factors including altered affinity for binding of receptors for both agonists and/or antagonists. differences in receptor density. and differences in the efficiency with which the agonists are coupled to their transduction mechanisms. adenylate cyclase and phospholipase C. Considering all these factors. the data suggest that endogenous dopamine-dopamine receptor interactions during this early period do not play a major role in control of pulmonary vascular tone.
After this period (group 1: 0-2 d) of fenoldopam and SCH 23390 interactions that might not be DAl receptor-specific responses. there are rather dramatic changes. in both the vascular responsiveness to fenoldopam and the DAI receptor-blocking activity of SCH 23390 that occur between 3 and 5 d of age. Fenoldopam-induced vasodilation, measured as a dose-response curve. in age group 2 is shifted to the left compared with both the younger (0-2 d) and older (6-23 d) animals. In contrast to group 1. a saturation point in the dose-response curve is reached (fenoldopam vasodilations at I .0 and 10.0 pg/g are not significantly different by repeated measures ANOVA). Also. in contrast with the earliest age group, the vasodilatory responses in this age group are significantly blunted by SCH 23390 (Fig. 3) . Taken together. these findings suggest that during this time period the enhanced vasodilatory action of fenoldopam is caused by stimulation of vascular DAI receptors. This increase in the pulmonary vascular responsiveness to DAI receptor manipulation may reflect changes occuning with maturation of autonomic innerva-
